GoingToMeet

Following the success of last year’s event, the SMi Group’s third annual conference on Adaptive Designs in Clinical Drug Development promises to be better than ever.

As adaptive designs begin to move from theoretical discussion to practical implementation, SMi’s conference will provide a panel of top speakers whose knowledge and experience will give you the edge in your clinical research. Implementing Bayesian statistical models will impact on every part of your drug development, so it will be vital to understand the implications of this change – from the move towards a “learn and confirm” paradigm and the increasing necessity of using EDC and similar technologies, to the changing regulatory environment and the impact on supplies and randomisation in the trials themselves.

Why should you attend this event?

* DISCOVER the latest adaptive trial designs from key statistical experts
* LEARN best practice and important tips for implementing an adaptive trial
* HEAR vital case studies from top pharmaceutical companies
* UNDERSTAND the impact of adaptive techniques on your pipeline and portfolio
* OPTIMISE your knowledge of the regulatory challenges for adaptive clinical trials
* NETWORK with key decision makers and leading specialists